Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints |
| |
摘 要: |
|
收稿时间: | 26 February 2020 |
本文献已被 ScienceDirect 等数据库收录! |
|